Fundz

Novasenta Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEJul 08, 2022$10M of $20M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Jul 8, 2022)

Round Type

Venture

PittsburghBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Novasenta Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Adastra raised an undisclosed amount on August 22, 2022.
  • Fennec Pharmaceuticals raised $5M on August 22, 2022.
  • Porton Advanced Solutions raised an undisclosed amount (Series B) on August 22, 2022.
  • Avelos Therapeutics raised an undisclosed amount (Series A) on August 22, 2022.
  • Ubie raised $26M (Series C) on August 22, 2022.
  • Rose Therapeutics raised $650K (Seed) on August 22, 2022.

Who to call at Novasenta Inc., and when

A new round usually means Novasenta Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Novasenta Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Novasenta Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Novasenta Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Novasenta Inc.

Location

350 TECHNOLOGY DRIVE

Pittsburgh, Pennsylvania, United States

About

Novasenta discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with cancer. We use systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. Our goal is to identify novel targets to generate effective therapies for a range of cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Novasenta Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPallavi T., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Novasenta Inc.'s next move

See what Strategic adds

Novasenta Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.